| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.077 | 0.09 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.042 | 0.4 |